GILD Prakiraan wutah bathi resik saben saham kanggo taun ngarep Gilead Sciences

gilead.com (GILD) - logo korporat

The EPS growth guidance for Gilead Sciences, Inc. (GILD) for the coming year reflects market expectations, with the value stabilizing at 1175.40. Gilead Sciences, Inc. (GILD) attracts top researchers by providing generous laboratory funding. High technological potential enables the development of cancer cell therapy and the fight against HIV. Dominance in the antiviral sector provides the capital necessary to acquire promising biotech startups.

GILD: Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Gilead 04.07.2022 - 18.11.2026

Rincian metrik komprehensif lan analitis Gilead Sciences (GILD)

Analisis fundamental perusahaan:Gilead Corp, GILD
Barang utama gilead.com

The fundamental value of Gilead Sciences, Inc. (GILD) is determined by its ability to generate stable cash flow from life-saving drugs. This metric measures the expected profit dynamics for the coming year, signaling a revision of analyst estimates under the influence of cost inflation. By analyzing the trends in the company's EPS forecasts for next year, an investor can identify institutional capital exit points. A decline in this metric offsets the effect of inertial demand, turning the asset into a vulnerable instrument.

Pesaing utama

Prakiraan wutah bathi saben saham kanggo taun ngarep CDTX|Prakiraan wutah bathi kanggo taun ngarep novavax.com|Prakiraan wutah bathi resik saben saham kanggo taun ngarep CureVac NV (CVAC)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Valneva Pharma|Prakiraan wutah bathi kanggo taun ngarep VIR (Vir Corp)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep SIGA Corp (SIGA)|Emergent BioSolutions Inc - Prakiraan wutah bathi kanggo taun ngarep|Atea Pharmaceuticals - Proyeksi tambahing bathi saben saham ing taun ngarep|IVVD (Invivyd Inc) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Enanta Pharmaceuticals Inc. (ENTA) - Prakiraan wutah bathi kanggo taun ngarep|INO (Inovio Pharma) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep HLVX|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Kalaris Therapeutics Inc (KLRS)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Dyadic International, Inc.|Prakiraan wutah bathi kanggo taun ngarep NNVC (nanoviricides.com)|Talphera Inc (TLPH) - Prakiraan wutah bathi resik saben saham ing taun ngarep|COCP: Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep TRAW|DWTX (Virios Therapeutics) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep QLGN|ALVR (AlloVir) - Prakiraan wutah bathi kanggo taun ngarep|vbivaccines.com (VBIV) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep VIRI|Prakiraan wutah bathi saben saham kanggo taun ngarep Vaxart Corp VXRT